ANADYS PHARMACEUTICALS INC 4
4 · ANADYS PHARMACEUTICALS INC · Filed Jun 7, 2005
Insider Transaction Report
Form 4
HBM BIOVENTURES AG
10% Owner
Transactions
- Sale
Common Stock
2005-06-06$7.63/sh−10,070$76,795→ 2,309,923 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-06$7.70/sh−10,680$82,249→ 2,254,705 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-06$7.51/sh−11,093$83,336→ 2,344,967 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-06$7.52/sh−15,065$113,248→ 2,329,902 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-06$7.81/sh−8,700$67,977→ 2,213,723 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-06$7.41/sh−8,500$62,974→ 2,428,824 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-06$7.73/sh−18,082$139,835→ 2,236,623 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-06$7.50/sh−36,991$277,433→ 2,370,610 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-06$7.80/sh−11,100$86,557→ 2,225,523 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-06$7.90/sh−5,700$45,052→ 2,208,023 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-06$7.40/sh−59,303$438,842→ 2,437,324 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-06$7.43/sh−21,223$157,649→ 2,407,601 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-06$7.80/sh−3,100$24,180→ 2,222,423 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-06$7.50/sh−14,550$109,176→ 2,356,060 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-06$7.60/sh−9,909$75,308→ 2,319,993 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-06$7.70/sh−44,538$342,943→ 2,265,385 total(indirect: By HBM BioVentures (Cayman) Ltd.)
Footnotes (2)
- [F1]HBM BioVentures AG (the "Reporting Entity") is the sole shareholder of HBM BioVentures (Cayman) Ltd. ("HBM"), the entity that owns the reported securities.
- [F2]N/A